drugset / Trial / NCT01352494

Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast Cancer

NCT01352494 ↗

Phase 2 Unknown 99 enrolled Korean Breast Cancer Study Group
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the response of docetaxel and gemcitabine in the neoadjuvant setting in women with locally advanced breast cancer.

Timeline

Start
2011-05
Primary completion
2013-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Docetaxel Small molecule 75 mg/m2 Intravenous
Subject Gemcitabine Small molecule 100 mg/m2 Intravenous